pull down to refresh

Shareholders of Core Scientific will receive 0.1235 CoreWeave shares for each share they hold. That implies a $20.40 per-share valuation and a 66% premium to Core Scientific's closing stock price before deal talks were reported.
After the deal closes, Core Scientific shareholders will own less than 10% of the combined company.
The two companies could have come together earlier. Last year Core Scientific said it had rejected CoreWeave's unsolicited offer to buy all outstanding shares.
JUST IN - Trump administration warns that U.S. blackouts could double by 2030 due to increased power demand driven by AI and coal plant closures.
reply